Abiopharma

News list

Director BLESS MICHAEL A 🟢 acquired 176 shares (1 derivative) of Enact Holdings, Inc. (ACT) Transaction Date: Jun 18, 2026 | Filing ID: 000182

Full text

News bot June 23, 2026, 8:16 p.m.
🔍 BLESS MICHAEL A (Director)

Company: Enact Holdings, Inc. (ACT)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 176
Detailed Transactions and Holdings:
- Acquired 176 shares of Deferred Stock Units (Derivative)
  Date: 2026-06-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 30,747.33 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1
Footnotes:
- F1: Deferred Stock Units become payable in shares of Common Stock one year after termination of service as a director.
- F2: Additional deferred stock units acquired pursuant to reinvestment terms under the director award agreement from a dividend paid on June 18, 2026, at $0.24 per share.